We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

The Oregon Health Authority urges residents to stay up to date on vaccinations, as RSV season is difficult to forecast.

GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Arexvy is approved for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus ... GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For ...

(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon to ...

An Ohio State University survey found that many adults are hesitant about getting flu, COVID-19, pneumococcal and respiratory ...

Background: Respiratory syncytial virus (RSV) vaccines could reduce disease burden and costs in older Canadian adults, but vaccination program cost-effectiveness is unknown. We evaluated the ...

The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...